Current UAEM Projects

University technology transfer

We aim to change the way universities commercialize drugs and other medical technologies, to protect low-cost access for the poor. This is UAEM's biggest and longest-running campaign, and is ongoing at universities around the world. [Read More]

University of California campaign

UAEM is making a special effort to engage the University of California, and encourage them to practice global access licensing for all new medical technologies. [Read More]

Technology transfer metrics

Developing new ways to measure the success of university technology transfer, emphasizing social impact. [Read More]

USA legislation

Campaigns around excessive protection of 'biologic' drug patents (2009), and global access provisions for federally funded research (2006). [Read More]

Canadian legislation

UAEM is supporting the efforts by the Canadian HIV/AIDS Legal Network to reform Canada's Access to Medicines Regime (CAMR), patent legislation intended to allow generic Canadian production of patented medications for export to poor countries, but underused due to excessive red tape. [Read More]

Bayh-Dole Act analogues

The Bayh-Dole Act (USA, 1980) governs the patenting and licensing of publicly funded research in the USA. It has a mixed record despite strong positive rhetoric. Similar Acts are now being developed in both India and South Africa. UAEM has analyzed the development of these new Acts. [Read More]

Neglected disease research

We try to stimulate more research and development to meet the needs of the poor, including on new treatments, diagnostics, and vaccines for neglected tropical diseases. [Read More]

Patent pools

UAEM is working to convince university technology transfer offices to engage with the patent pools being developed by UNITAID (for HIV drugs) and GlaxoSmithKline (for neglected diseases). [Read More]

International agreements

UAEM is participating in the discussions of the WHO's Intergovernmental Working Group on Public Health, Innovation and Intellectual Property. [Read More]

Student empowerment

We help students carry out successful campaigns on university campuses worldwide. We provide educational resources (including this web site) and individual advice, and we organize an annual conference. [Read More]

Für deutschsprachige Interessierte besuchen Sie gerne auch die Website von UAEM Deutschland unter: http://www.uaem-germany.de

Read more about the push to reform Canada's Access to Medicines Regime at http://www.aidslaw.ca/camr.

UAEM News

UAEM Executive Director Ethan Guillen Advocates the Right to Life-Saving Medicines to AAAS Science and the Human Rights Coalition - 6 Aug 2010
  AAAS, an international non-profit organization dedicated to advocating science around the world, invited members of the Human Rights Coalition to explore the right to access live-saving... [Read More]
UAEMers Sandeep Kishore and Rajesh Panjabi Profiled in Lives, a Scientific American Publication - 28 Jul 2010
UAEMers Sandeep Kishore and Rajesh Panjabi Profiled in Lives, a Scientific American Publication, alongside President Jimmy Carter and six others "tied together by clarity of purpose, by strength and... [Read More]
UAEM's Call for GWU to to Cease Industry-Sponsored Intellectual Property Training in India Picked up on PharmaBiz.com - 28 Jul 2010
The letter UAEM and several other NGOs wrote to George Washington University calling for the cessation of it's industry-sponsored intellectual property (IP) training in India was picked up India-... [Read More]
Letter to Nature Reviews Microbiology in Support of Generics - 28 Jul 2010
UAEM's Sandeep Kishore and Karolina Maciag submitted a letter to Nature Reviews Microbiology,  published online on 7 June 2010, titled "Generic Drugs for Developing Nations" in response to a... [Read More]
UAEM Featured in University of Edinburgh Annual Review - 28 Jul 2010
The University of Edinburgh featured UAEM's work, including UAEM's UK national coordinator Mori Mansouri, in their annual review. The University has taken a leadership role as one of the first... [Read More]

Home